Mayo Clinic study suggests patients with lung cancer be screened for MET oncogene

ROCHESTER, Minn. — Research by investigators at Mayo Clinic Cancer Center suggests that physicians should screen patients with lung cancer for MET amplification/overexpression before determining a treatment strategy. Their findings are published Cancer Discovery, a journal of the American Association for Cancer R esearch. “In our research we found several lung cancer cases that were not responsive to standard chemotherapy,” says Zhenkun Lou, Ph.D., a cancer researcher at Mayo Clinic. “Because these lung cancers were positive for…
Source: Mayo Clinic Minnesota News - Category: Hospital Management Source Type: news